Let's Chat About Cats
Discover how BRAVECTO® PLUS can benefit your clinic, your clients, and your patients’ lives.
First, Let's Dispel Some Myths
Next, Let's Review Peer-Reviewed Content
Client Handout: Heartworm Disease in Cats
- 1. BRAVECTO® PLUS [product label]. Madison, NJ: Merck Animal Health; 2019.
- 2. Lavan R, Normile D, Armstrong R, Vaala W. Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto® Topical Solution for Cats). Open Vet J. 2021;11:80–88.
3. REVOLUTION PLUS® [product label]. Kalamazoo, MI: Zoetis Inc; 2018.
For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.
BRAVECTO PLUS for Cats is for cats 6 months of age or older. Side effects may include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. Use with caution in cats with a history of neurologic disorders. Use with caution in cats that are heartworm positive.
IMPORTANT SAFETY INFORMATION
The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. For topical use only. Avoid oral ingestion. The safety of BRAVECTO PLUS has not been established in breeding, pregnant and lactating cats. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia , and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.